IPOs: Delayed

By Staff Reporters

***

***

Initial Public Offering Defined

IPO stands for initial public offering. It is when a company takes a portion of their shares and makes them available for the general public to buy on the open market. It is a way for the company to raise money by selling those shares to the general public. You can usually access shares from an IPO by working directly with an investment bank.

Paused IPOs

Private companies StubHub and Klarna each paused their imminent plans to go public.

Klarna, which was set to IPO on this Monday, was expected to jump-start the frozen IPO market this year with an expected ~$15 billion valuation.

StubHub, meanwhile, reportedly wants to wait for the market to calm down before resuming its plans to go public.

COMMENTS APPRECIATED

Refer, Read, Like and Subscribe

***

***

StubHub! Plans to Go Public?

By Staff Reporters

***

***

StubHub is an American ticket exchange and resale company. It provides services for buyers and sellers of tickets for sports, concerts, theater, and other live entertainment events. By 2015, it was the world’s largest ticket marketplace. While the company does not currently disclose its financials, in 2015 it had over 16 million unique visitors and nearly 10 million live events per month. StubHub was founded in 2000 by Eric Baker and Jeff Fluhr. The company was acquired by eBay for $310 million in 2007, and again acquired in 2020 by Viagogo.

StubHub reportedly plans to go public this summer?

According to The Information, the ticketing giant was last valued at $16.5 billion in 2021, but could still call off the public listing if it fails to land that figure.

The news comes amid a post-pandemic resurgence for live events, boosted by massive tours from Beyoncé and Taylor Swift. Though StubHub revenue jumped 40% in 2023 from the year before, it’s saddled with more than $2 billion in debt, which could test investors’ willingness to buy.

Rival ticketing service SeatGeek is also said to be mulling an IPO later this year.

COMMENTS APPRECIATED?

Subscribe today

***

***